Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Individuals living in areas where malaria is endemic are repeatedly exposed to many different malaria parasite antigens. Studies on naturally acquired antibody-mediated immunity to clinical malaria have largely focused on the presence of responses to individual antigens and their associations with d...

Bibliográfalaš dieđut
Váldodahkkit:	Osier, F, Fegan, G, Polley, S, Murungi, L, Verra, F, Tetteh, K, Lowe, B, Mwangi, T, Bull, P, Thomas, A, Cavanagh, DR, McBride, J, Lanar, D, Mackinnon, M, Conway, D, Marsh, K
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2008

Geahča maid

Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
Dahkki: Osier, F, et al.
Almmustuhtton: (2010)

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
Dahkki: Osier, F, et al.
Almmustuhtton: (2007)

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Dahkki: Polley, S, et al.
Almmustuhtton: (2006)

A detailed study of the kinetics of antibody responses to Plasmodium falciparum merozoite antigens [MIM-SK-10044]
Dahkki: Kinyanjui, S, et al.
Almmustuhtton: (2005)

Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.
Dahkki: Rono, J, et al.
Almmustuhtton: (2013)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
Dahkki: Murungi, L, et al.
Almmustuhtton: (2013)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
Dahkki: Murungi, L, et al.
Almmustuhtton: (2013)

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.
Dahkki: Kinyanjui, S, et al.
Almmustuhtton: (2007)

Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.
Dahkki: Dobaño, C, et al.
Almmustuhtton: (2008)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) is apically localized in free merozoites and antibodies are associated with reduced risk of malaria
Dahkki: Aniweh, Y, et al.
Almmustuhtton: (2020)

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.
Dahkki: Osier, F, et al.
Almmustuhtton: (2010)

Allele-specific antibody reactivities to MSP-3 and protection from malaria [MIM-FO-44148]
Dahkki: Osier, F, et al.
Almmustuhtton: (2005)

Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.
Dahkki: Tetteh, K, et al.
Almmustuhtton: (2013)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria
Dahkki: Yaw Aniweh, et al.
Almmustuhtton: (2020-04-01)

Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family.
Dahkki: Verra, F, et al.
Almmustuhtton: (2006)

Dynamics and role of antibodies to Plasmodium falciparum merozoite antigens in children living in two settings with differing malaria transmission intensity.
Dahkki: Kangoye, D, et al.
Almmustuhtton: (2016)

IgG antibody responses to <it>Plasmodium falciparum </it>merozoite antigens in Kenyan children have a short half-life
Dahkki: Lanar David E, et al.
Almmustuhtton: (2007-06-01)

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.
Dahkki: Verra, F, et al.
Almmustuhtton: (2007)

The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.
Dahkki: Sarah I Nogaro, et al.
Almmustuhtton: (2011-01-01)

Studies of natural selection on malaria parasite merozoites in relation to invasion and immunity.
Dahkki: Tetteh, K, et al.
Almmustuhtton: (2008)

A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins.
Dahkki: Crosnier, C, et al.
Almmustuhtton: (2013)

Allele frequency based tests of neutrality on eba-175 and ebl-1 in Plasmodium falciparum populations from Kenya and Thailand [MIM-FV-66780]
Dahkki: Verra, F, et al.
Almmustuhtton: (2005)

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.
Dahkki: Ochola-Oyier, L, et al.
Almmustuhtton: (2016)

KILchip v1.0: a novel plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization
Dahkki: Kamuyu, G, et al.
Almmustuhtton: (2018)

Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.
Dahkki: Cavanagh, DR, et al.
Almmustuhtton: (2001)

The acquisition and maintenance of antibodies against Plasmodium falciparum merozoite antigens in childhood
Dahkki: Mugyenyi, C, et al.
Almmustuhtton: (2007)

The acquisition and maintenance of antibodies against P-falciparum merozoite antigens in childhood.
Dahkki: Mugyenyi, C, et al.
Almmustuhtton: (2008)

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
Dahkki: Polley, S, et al.
Almmustuhtton: (2004)

Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
Dahkki: Osier, F, et al.
Almmustuhtton: (2014)

Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure
Dahkki: Yman, V, et al.
Almmustuhtton: (2019)

Magnitude of role-breadth self-efficacy in teacher proactive work behaviour
Dahkki: Peariasamy, Suguna Devi, et al.
Almmustuhtton: (2020)

Dynamics of the Magnitude, Breadth and Depth of the Antibody Response at Epitope Level Following Dengue Infection
Dahkki: Francesca Falconi-Agapito, et al.
Almmustuhtton: (2021-07-01)

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.
Dahkki: Federica Verra, et al.
Almmustuhtton: (2007-10-01)

HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
Dahkki: Chelsea N. Fries, et al.
Almmustuhtton: (2021-07-01)

Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.
Dahkki: Murungi, L, et al.
Almmustuhtton: (2016)

34 Novel conserved element HIV/SIV DNA vaccines maximize breadth and magnitude of immune response
Dahkki: B.K. Felber, et al.
Almmustuhtton: (2016-07-01)

Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection
Dahkki: Ochola-Oyier, L, et al.
Almmustuhtton: (2019)

Complement activation by merozoite antigens of Plasmodium falciparum.
Dahkki: Jackson C Korir, et al.
Almmustuhtton: (2014-01-01)

Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target
Dahkki: Karamoko Niaré, et al.
Almmustuhtton: (2023-04-01)

Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
Dahkki: David R Cavanagh, et al.
Almmustuhtton: (2014-01-01)